Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


US Insurers, Hospitals, Medtech Industry Say Transparency Rule Touted In President’s Speech Is Anticompetitive

Trump says transparency rule ‘bigger than health care reform’ while hospitals file suit against it

Executive Summary

US President Donald Trump in his State of the Union address on 4 February touted his 2019 Price Transparency executive order calling on federal agencies to require private hospitals and insurers to publicly reveal the costs of hundreds of their device-related procedures and lab tests – as well as insurers’ negotiated rates for them – so patients can shop for their own health care. But industry maintains the resulting rules out of the Centers for Medicare and Medicaid Services are “anticompetitive,” and a coalition of hospital groups is suing the Department of Health and Human Services to stop their implementation.

You may also be interested in...

Bill To Lower Pay Of Out-Of-Network Physicians, Costs Delayed To 2020

A bill meant to stop out-of-network "surprise billing" may have stalled but is likely to make a reappearance when Congress reconvenes next year according to lawmakers and experts. Despite support in key Senate and House committees, the bill hit a wall when lawmakers introduced an alternative version in the House Ways and Means Committee late in the legislative session.

CMS Hospital Price Transparency Rule To Begin Public Reveal Of Device-Related Procedure Prices, Test Costs In 2021

The US Medicare agency on 15 November released a final cost transparency rule calling on hospitals to detail their standard “shoppable services” charges for X-rays, advanced imaging, laboratory tests and an array of other device-related procedures, beginning on 1 January 2021. Meanwhile, an accompanying proposed rule released by the CMS on the same day would require insurance health plans to provide to participants and beneficiaries the insurers’ negotiated rates for all covered health-care items and services.

AdvaMed Pans CMS Plan To Mandate Publicizing Hospital Rates, But Likes Pay Path For Breakthrough Devices

AdvaMed took issue with several aspects of a US Centers for Medicare and Medicaid Services (CMS) outpatient payment system draft rule mandating that hospitals publicize prices for their surgical procedures and laboratory tests, in comments on the draft. But the medtech industry advocacy group, as well as the Medical Device Manufacturers Association (MDMA), say they support another provision – the agency's new Medicare coverage and payment proposal for breakthrough devices – and requested only minor tweaks to the plan.

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts